HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 84 filers reported holding HARVARD BIOSCIENCE INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $319,000 | +20.4% | 104,579 | +7.4% | 0.00% | – |
| Q3 2016 | $265,000 | +16.2% | 97,351 | +22.2% | 0.00% | – |
| Q2 2016 | $228,000 | -91.3% | 79,697 | -90.8% | 0.00% | -100.0% |
| Q1 2016 | $2,630,000 | -12.9% | 870,740 | +0.0% | 0.00% | 0.0% |
| Q4 2015 | $3,020,000 | -5.2% | 870,359 | +3.3% | 0.00% | 0.0% |
| Q3 2015 | $3,185,000 | -34.5% | 842,557 | -1.2% | 0.00% | 0.0% |
| Q2 2015 | $4,860,000 | +989.7% | 852,598 | +1013.3% | 0.00% | – |
| Q1 2015 | $446,000 | -3.9% | 76,580 | -6.3% | 0.00% | – |
| Q4 2014 | $464,000 | +49.2% | 81,764 | +7.7% | 0.00% | – |
| Q3 2014 | $311,000 | -16.2% | 75,932 | -6.8% | 0.00% | – |
| Q2 2014 | $371,000 | -89.3% | 81,444 | -88.9% | 0.00% | -100.0% |
| Q1 2014 | $3,477,000 | +5.1% | 733,569 | +4.2% | 0.00% | 0.0% |
| Q4 2013 | $3,308,000 | -15.7% | 703,805 | -5.6% | 0.00% | 0.0% |
| Q3 2013 | $3,923,000 | +23.7% | 745,829 | +10.6% | 0.00% | 0.0% |
| Q2 2013 | $3,171,000 | – | 674,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |